nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A1—Dacarbazine—pancreatic cancer	0.131	0.161	CbGbCtD
Methoxsalen—CYP2A6—Tamoxifen—pancreatic cancer	0.122	0.149	CbGbCtD
Methoxsalen—CYP1A1—Tamoxifen—pancreatic cancer	0.105	0.128	CbGbCtD
Methoxsalen—CYP2A6—Fluorouracil—pancreatic cancer	0.0901	0.11	CbGbCtD
Methoxsalen—CYP1A1—Erlotinib—pancreatic cancer	0.0889	0.109	CbGbCtD
Methoxsalen—CYP1A2—Dacarbazine—pancreatic cancer	0.0587	0.0717	CbGbCtD
Methoxsalen—CYP1A2—Tamoxifen—pancreatic cancer	0.0467	0.057	CbGbCtD
Methoxsalen—CYP1A2—Erlotinib—pancreatic cancer	0.0397	0.0485	CbGbCtD
Methoxsalen—CYP1A2—Fluorouracil—pancreatic cancer	0.0344	0.042	CbGbCtD
Methoxsalen—CYP3A4—Tamoxifen—pancreatic cancer	0.0245	0.0299	CbGbCtD
Methoxsalen—CYP3A4—Erlotinib—pancreatic cancer	0.0208	0.0254	CbGbCtD
Methoxsalen—CYP3A4—Irinotecan—pancreatic cancer	0.0188	0.0229	CbGbCtD
Methoxsalen—CYP3A4—Docetaxel—pancreatic cancer	0.0138	0.0168	CbGbCtD
Methoxsalen—CYP3A4—Sunitinib—pancreatic cancer	0.0137	0.0167	CbGbCtD
Methoxsalen—CYP3A4—Doxorubicin—pancreatic cancer	0.0103	0.0125	CbGbCtD
Methoxsalen—Dermatitis acneiform—Erlotinib—pancreatic cancer	0.00583	0.0321	CcSEcCtD
Methoxsalen—Leukoderma—Sunitinib—pancreatic cancer	0.00406	0.0224	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Erlotinib—pancreatic cancer	0.00335	0.0185	CcSEcCtD
Methoxsalen—Folliculitis—Erlotinib—pancreatic cancer	0.00317	0.0175	CcSEcCtD
Methoxsalen—Redness—Tamoxifen—pancreatic cancer	0.00298	0.0164	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Sunitinib—pancreatic cancer	0.0029	0.016	CcSEcCtD
Methoxsalen—Blister—Tamoxifen—pancreatic cancer	0.00279	0.0154	CcSEcCtD
Methoxsalen—Blister—Erlotinib—pancreatic cancer	0.00276	0.0152	CcSEcCtD
Methoxsalen—Lupus erythematosus—Docetaxel—pancreatic cancer	0.00264	0.0145	CcSEcCtD
Methoxsalen—Blister—Sunitinib—pancreatic cancer	0.00239	0.0132	CcSEcCtD
Methoxsalen—Tenderness—Tamoxifen—pancreatic cancer	0.00231	0.0127	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Fluorouracil—pancreatic cancer	0.00229	0.0126	CcSEcCtD
Methoxsalen—Tenderness—Erlotinib—pancreatic cancer	0.00228	0.0126	CcSEcCtD
Methoxsalen—Inflammation—Tamoxifen—pancreatic cancer	0.00208	0.0114	CcSEcCtD
Methoxsalen—Inflammation—Erlotinib—pancreatic cancer	0.00205	0.0113	CcSEcCtD
Methoxsalen—Skin exfoliation—Tamoxifen—pancreatic cancer	0.00192	0.0106	CcSEcCtD
Methoxsalen—Skin exfoliation—Erlotinib—pancreatic cancer	0.0019	0.0105	CcSEcCtD
Methoxsalen—Blister—Fluorouracil—pancreatic cancer	0.00189	0.0104	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Tamoxifen—pancreatic cancer	0.00185	0.0102	CcSEcCtD
Methoxsalen—Systemic lupus erythematosus—Docetaxel—pancreatic cancer	0.00177	0.00977	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Docetaxel—pancreatic cancer	0.00165	0.0091	CcSEcCtD
Methoxsalen—Skin exfoliation—Sunitinib—pancreatic cancer	0.00165	0.00907	CcSEcCtD
Methoxsalen—Tenderness—Gemcitabine—pancreatic cancer	0.00159	0.00874	CcSEcCtD
Methoxsalen—Tenderness—Fluorouracil—pancreatic cancer	0.00156	0.00859	CcSEcCtD
Methoxsalen—Leukoderma—Epirubicin—pancreatic cancer	0.00156	0.00859	CcSEcCtD
Methoxsalen—Dermatitis bullous—Tamoxifen—pancreatic cancer	0.00153	0.00843	CcSEcCtD
Methoxsalen—Dermatitis bullous—Erlotinib—pancreatic cancer	0.00151	0.00834	CcSEcCtD
Methoxsalen—Herpes simplex—Fluorouracil—pancreatic cancer	0.00148	0.00814	CcSEcCtD
Methoxsalen—Redness—Docetaxel—pancreatic cancer	0.00146	0.00802	CcSEcCtD
Methoxsalen—Leukoderma—Doxorubicin—pancreatic cancer	0.00144	0.00794	CcSEcCtD
Methoxsalen—Inflammation—Fluorouracil—pancreatic cancer	0.0014	0.00773	CcSEcCtD
Methoxsalen—Dry skin—Erlotinib—pancreatic cancer	0.00133	0.0073	CcSEcCtD
Methoxsalen—Skin exfoliation—Gemcitabine—pancreatic cancer	0.00132	0.00728	CcSEcCtD
Methoxsalen—Dermatitis bullous—Sunitinib—pancreatic cancer	0.00131	0.00722	CcSEcCtD
Methoxsalen—Dry skin—Sunitinib—pancreatic cancer	0.00115	0.00632	CcSEcCtD
Methoxsalen—Depression—Tamoxifen—pancreatic cancer	0.00112	0.00619	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Epirubicin—pancreatic cancer	0.00111	0.00614	CcSEcCtD
Methoxsalen—Depression—Erlotinib—pancreatic cancer	0.00111	0.00612	CcSEcCtD
Methoxsalen—Folliculitis—Epirubicin—pancreatic cancer	0.00105	0.00581	CcSEcCtD
Methoxsalen—Dermatitis bullous—Gemcitabine—pancreatic cancer	0.00105	0.00579	CcSEcCtD
Methoxsalen—Dermatitis bullous—Fluorouracil—pancreatic cancer	0.00103	0.00569	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Doxorubicin—pancreatic cancer	0.00103	0.00568	CcSEcCtD
Methoxsalen—Inflammation—Docetaxel—pancreatic cancer	0.00101	0.00558	CcSEcCtD
Methoxsalen—Redness—Epirubicin—pancreatic cancer	0.000982	0.00541	CcSEcCtD
Methoxsalen—Folliculitis—Doxorubicin—pancreatic cancer	0.000975	0.00537	CcSEcCtD
Methoxsalen—Depression—Sunitinib—pancreatic cancer	0.000962	0.0053	CcSEcCtD
Methoxsalen—Skin exfoliation—Docetaxel—pancreatic cancer	0.000938	0.00517	CcSEcCtD
Methoxsalen—Blister—Epirubicin—pancreatic cancer	0.000919	0.00506	CcSEcCtD
Methoxsalen—Redness—Doxorubicin—pancreatic cancer	0.000908	0.005	CcSEcCtD
Methoxsalen—Dry skin—Fluorouracil—pancreatic cancer	0.000906	0.00499	CcSEcCtD
Methoxsalen—Arrhythmia—Tamoxifen—pancreatic cancer	0.000904	0.00498	CcSEcCtD
Methoxsalen—Arrhythmia—Erlotinib—pancreatic cancer	0.000894	0.00492	CcSEcCtD
Methoxsalen—Erythema—Tamoxifen—pancreatic cancer	0.000881	0.00485	CcSEcCtD
Methoxsalen—Erythema—Erlotinib—pancreatic cancer	0.000871	0.0048	CcSEcCtD
Methoxsalen—Dysgeusia—Tamoxifen—pancreatic cancer	0.000862	0.00475	CcSEcCtD
Methoxsalen—Blister—Doxorubicin—pancreatic cancer	0.000851	0.00469	CcSEcCtD
Methoxsalen—Muscle spasms—Tamoxifen—pancreatic cancer	0.000847	0.00466	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.000779	0.00429	CcSEcCtD
Methoxsalen—Arrhythmia—Sunitinib—pancreatic cancer	0.000774	0.00426	CcSEcCtD
Methoxsalen—Erythema—Sunitinib—pancreatic cancer	0.000754	0.00415	CcSEcCtD
Methoxsalen—Dermatitis bullous—Docetaxel—pancreatic cancer	0.000746	0.00411	CcSEcCtD
Methoxsalen—Discomfort—Tamoxifen—pancreatic cancer	0.000741	0.00408	CcSEcCtD
Methoxsalen—Dysgeusia—Sunitinib—pancreatic cancer	0.000739	0.00407	CcSEcCtD
Methoxsalen—Muscle spasms—Sunitinib—pancreatic cancer	0.000725	0.00399	CcSEcCtD
Methoxsalen—Herpes simplex—Epirubicin—pancreatic cancer	0.000719	0.00396	CcSEcCtD
Methoxsalen—Oedema—Tamoxifen—pancreatic cancer	0.000719	0.00396	CcSEcCtD
Methoxsalen—Infection—Tamoxifen—pancreatic cancer	0.000714	0.00393	CcSEcCtD
Methoxsalen—Oedema—Erlotinib—pancreatic cancer	0.000711	0.00392	CcSEcCtD
Methoxsalen—Infection—Erlotinib—pancreatic cancer	0.000706	0.00389	CcSEcCtD
Methoxsalen—Skin disorder—Erlotinib—pancreatic cancer	0.000691	0.0038	CcSEcCtD
Methoxsalen—Inflammation—Epirubicin—pancreatic cancer	0.000683	0.00376	CcSEcCtD
Methoxsalen—Herpes simplex—Doxorubicin—pancreatic cancer	0.000665	0.00366	CcSEcCtD
Methoxsalen—Dry skin—Docetaxel—pancreatic cancer	0.000654	0.0036	CcSEcCtD
Methoxsalen—Insomnia—Tamoxifen—pancreatic cancer	0.00065	0.00358	CcSEcCtD
Methoxsalen—Insomnia—Erlotinib—pancreatic cancer	0.000643	0.00354	CcSEcCtD
Methoxsalen—Arrhythmia—Irinotecan—pancreatic cancer	0.000637	0.00351	CcSEcCtD
Methoxsalen—Skin exfoliation—Epirubicin—pancreatic cancer	0.000633	0.00348	CcSEcCtD
Methoxsalen—Dyspepsia—Tamoxifen—pancreatic cancer	0.000633	0.00348	CcSEcCtD
Methoxsalen—Inflammation—Doxorubicin—pancreatic cancer	0.000632	0.00348	CcSEcCtD
Methoxsalen—Dyspepsia—Erlotinib—pancreatic cancer	0.000626	0.00345	CcSEcCtD
Methoxsalen—Arrhythmia—Gemcitabine—pancreatic cancer	0.000621	0.00342	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00062	0.00342	CcSEcCtD
Methoxsalen—Oedema—Sunitinib—pancreatic cancer	0.000615	0.00339	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000614	0.00338	CcSEcCtD
Methoxsalen—Infection—Sunitinib—pancreatic cancer	0.000611	0.00337	CcSEcCtD
Methoxsalen—Arrhythmia—Fluorouracil—pancreatic cancer	0.000611	0.00336	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Epirubicin—pancreatic cancer	0.000609	0.00335	CcSEcCtD
Methoxsalen—Erythema—Gemcitabine—pancreatic cancer	0.000605	0.00333	CcSEcCtD
Methoxsalen—Skin disorder—Sunitinib—pancreatic cancer	0.000598	0.00329	CcSEcCtD
Methoxsalen—Muscle spasms—Irinotecan—pancreatic cancer	0.000597	0.00329	CcSEcCtD
Methoxsalen—Erythema—Fluorouracil—pancreatic cancer	0.000595	0.00328	CcSEcCtD
Methoxsalen—Skin exfoliation—Doxorubicin—pancreatic cancer	0.000585	0.00322	CcSEcCtD
Methoxsalen—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000576	0.00318	CcSEcCtD
Methoxsalen—Urticaria—Tamoxifen—pancreatic cancer	0.000571	0.00314	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Doxorubicin—pancreatic cancer	0.000563	0.0031	CcSEcCtD
Methoxsalen—Body temperature increased—Erlotinib—pancreatic cancer	0.000562	0.0031	CcSEcCtD
Methoxsalen—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000561	0.00309	CcSEcCtD
Methoxsalen—Malaise—Irinotecan—pancreatic cancer	0.00056	0.00309	CcSEcCtD
Methoxsalen—Vertigo—Irinotecan—pancreatic cancer	0.000558	0.00307	CcSEcCtD
Methoxsalen—Insomnia—Sunitinib—pancreatic cancer	0.000557	0.00307	CcSEcCtD
Methoxsalen—Malaise—Gemcitabine—pancreatic cancer	0.000546	0.00301	CcSEcCtD
Methoxsalen—Dyspepsia—Sunitinib—pancreatic cancer	0.000542	0.00298	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000531	0.00293	CcSEcCtD
Methoxsalen—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000529	0.00292	CcSEcCtD
Methoxsalen—Discomfort—Irinotecan—pancreatic cancer	0.000523	0.00288	CcSEcCtD
Methoxsalen—Discomfort—Gemcitabine—pancreatic cancer	0.000509	0.0028	CcSEcCtD
Methoxsalen—Pruritus—Tamoxifen—pancreatic cancer	0.000508	0.0028	CcSEcCtD
Methoxsalen—Oedema—Irinotecan—pancreatic cancer	0.000507	0.00279	CcSEcCtD
Methoxsalen—Infection—Irinotecan—pancreatic cancer	0.000504	0.00277	CcSEcCtD
Methoxsalen—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000503	0.00277	CcSEcCtD
Methoxsalen—Pruritus—Erlotinib—pancreatic cancer	0.000503	0.00277	CcSEcCtD
Methoxsalen—Discomfort—Fluorouracil—pancreatic cancer	0.0005	0.00276	CcSEcCtD
Methoxsalen—Oedema—Gemcitabine—pancreatic cancer	0.000494	0.00272	CcSEcCtD
Methoxsalen—Infection—Gemcitabine—pancreatic cancer	0.000491	0.0027	CcSEcCtD
Methoxsalen—Body temperature increased—Sunitinib—pancreatic cancer	0.000487	0.00268	CcSEcCtD
Methoxsalen—Oedema—Fluorouracil—pancreatic cancer	0.000486	0.00267	CcSEcCtD
Methoxsalen—Infection—Fluorouracil—pancreatic cancer	0.000482	0.00266	CcSEcCtD
Methoxsalen—Skin disorder—Gemcitabine—pancreatic cancer	0.00048	0.00264	CcSEcCtD
Methoxsalen—Dizziness—Tamoxifen—pancreatic cancer	0.000475	0.00262	CcSEcCtD
Methoxsalen—Hypotension—Irinotecan—pancreatic cancer	0.000474	0.00261	CcSEcCtD
Methoxsalen—Dizziness—Erlotinib—pancreatic cancer	0.00047	0.00259	CcSEcCtD
Methoxsalen—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000466	0.00256	CcSEcCtD
Methoxsalen—Hypotension—Gemcitabine—pancreatic cancer	0.000461	0.00254	CcSEcCtD
Methoxsalen—Insomnia—Irinotecan—pancreatic cancer	0.000459	0.00253	CcSEcCtD
Methoxsalen—Hypotension—Fluorouracil—pancreatic cancer	0.000454	0.0025	CcSEcCtD
Methoxsalen—Hypersensitivity—Sunitinib—pancreatic cancer	0.000453	0.0025	CcSEcCtD
Methoxsalen—Rash—Tamoxifen—pancreatic cancer	0.000453	0.0025	CcSEcCtD
Methoxsalen—Dermatitis—Tamoxifen—pancreatic cancer	0.000453	0.00249	CcSEcCtD
Methoxsalen—Headache—Tamoxifen—pancreatic cancer	0.00045	0.00248	CcSEcCtD
Methoxsalen—Rash—Erlotinib—pancreatic cancer	0.000448	0.00247	CcSEcCtD
Methoxsalen—Dermatitis—Erlotinib—pancreatic cancer	0.000448	0.00247	CcSEcCtD
Methoxsalen—Insomnia—Gemcitabine—pancreatic cancer	0.000447	0.00246	CcSEcCtD
Methoxsalen—Dyspepsia—Irinotecan—pancreatic cancer	0.000446	0.00246	CcSEcCtD
Methoxsalen—Headache—Erlotinib—pancreatic cancer	0.000445	0.00245	CcSEcCtD
Methoxsalen—Dry skin—Epirubicin—pancreatic cancer	0.000441	0.00243	CcSEcCtD
Methoxsalen—Arrhythmia—Docetaxel—pancreatic cancer	0.000441	0.00243	CcSEcCtD
Methoxsalen—Insomnia—Fluorouracil—pancreatic cancer	0.000439	0.00242	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000438	0.00241	CcSEcCtD
Methoxsalen—Pruritus—Sunitinib—pancreatic cancer	0.000435	0.0024	CcSEcCtD
Methoxsalen—Erythema—Docetaxel—pancreatic cancer	0.000429	0.00237	CcSEcCtD
Methoxsalen—Dyspepsia—Fluorouracil—pancreatic cancer	0.000427	0.00235	CcSEcCtD
Methoxsalen—Nausea—Tamoxifen—pancreatic cancer	0.000427	0.00235	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000426	0.00235	CcSEcCtD
Methoxsalen—Nausea—Erlotinib—pancreatic cancer	0.000422	0.00233	CcSEcCtD
Methoxsalen—Dysgeusia—Docetaxel—pancreatic cancer	0.000421	0.00232	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000419	0.00231	CcSEcCtD
Methoxsalen—Feeling abnormal—Irinotecan—pancreatic cancer	0.000418	0.0023	CcSEcCtD
Methoxsalen—Muscle spasms—Docetaxel—pancreatic cancer	0.000413	0.00227	CcSEcCtD
Methoxsalen—Dry skin—Doxorubicin—pancreatic cancer	0.000408	0.00225	CcSEcCtD
Methoxsalen—Dizziness—Sunitinib—pancreatic cancer	0.000407	0.00224	CcSEcCtD
Methoxsalen—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000407	0.00224	CcSEcCtD
Methoxsalen—Body temperature increased—Irinotecan—pancreatic cancer	0.000401	0.00221	CcSEcCtD
Methoxsalen—Feeling abnormal—Fluorouracil—pancreatic cancer	0.0004	0.0022	CcSEcCtD
Methoxsalen—Body temperature increased—Gemcitabine—pancreatic cancer	0.00039	0.00215	CcSEcCtD
Methoxsalen—Rash—Sunitinib—pancreatic cancer	0.000388	0.00214	CcSEcCtD
Methoxsalen—Dermatitis—Sunitinib—pancreatic cancer	0.000388	0.00214	CcSEcCtD
Methoxsalen—Urticaria—Fluorouracil—pancreatic cancer	0.000386	0.00212	CcSEcCtD
Methoxsalen—Headache—Sunitinib—pancreatic cancer	0.000386	0.00212	CcSEcCtD
Methoxsalen—Body temperature increased—Fluorouracil—pancreatic cancer	0.000384	0.00211	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000379	0.00209	CcSEcCtD
Methoxsalen—Hypersensitivity—Irinotecan—pancreatic cancer	0.000374	0.00206	CcSEcCtD
Methoxsalen—Nausea—Sunitinib—pancreatic cancer	0.000366	0.00201	CcSEcCtD
Methoxsalen—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000358	0.00197	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000351	0.00193	CcSEcCtD
Methoxsalen—Oedema—Docetaxel—pancreatic cancer	0.00035	0.00193	CcSEcCtD
Methoxsalen—Pruritus—Gemcitabine—pancreatic cancer	0.000349	0.00192	CcSEcCtD
Methoxsalen—Infection—Docetaxel—pancreatic cancer	0.000348	0.00192	CcSEcCtD
Methoxsalen—Pruritus—Fluorouracil—pancreatic cancer	0.000344	0.00189	CcSEcCtD
Methoxsalen—Skin disorder—Docetaxel—pancreatic cancer	0.00034	0.00188	CcSEcCtD
Methoxsalen—Dizziness—Irinotecan—pancreatic cancer	0.000335	0.00185	CcSEcCtD
Methoxsalen—Hypotension—Docetaxel—pancreatic cancer	0.000327	0.0018	CcSEcCtD
Methoxsalen—Dizziness—Fluorouracil—pancreatic cancer	0.000321	0.00177	CcSEcCtD
Methoxsalen—Rash—Irinotecan—pancreatic cancer	0.00032	0.00176	CcSEcCtD
Methoxsalen—Dermatitis—Irinotecan—pancreatic cancer	0.000319	0.00176	CcSEcCtD
Methoxsalen—Headache—Irinotecan—pancreatic cancer	0.000318	0.00175	CcSEcCtD
Methoxsalen—Insomnia—Docetaxel—pancreatic cancer	0.000317	0.00175	CcSEcCtD
Methoxsalen—Rash—Gemcitabine—pancreatic cancer	0.000311	0.00172	CcSEcCtD
Methoxsalen—Dermatitis—Gemcitabine—pancreatic cancer	0.000311	0.00171	CcSEcCtD
Methoxsalen—Headache—Gemcitabine—pancreatic cancer	0.000309	0.0017	CcSEcCtD
Methoxsalen—Dyspepsia—Docetaxel—pancreatic cancer	0.000309	0.0017	CcSEcCtD
Methoxsalen—Rash—Fluorouracil—pancreatic cancer	0.000306	0.00169	CcSEcCtD
Methoxsalen—Dermatitis—Fluorouracil—pancreatic cancer	0.000306	0.00168	CcSEcCtD
Methoxsalen—Headache—Fluorouracil—pancreatic cancer	0.000304	0.00168	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000303	0.00167	CcSEcCtD
Methoxsalen—Nausea—Irinotecan—pancreatic cancer	0.000301	0.00166	CcSEcCtD
Methoxsalen—Arrhythmia—Epirubicin—pancreatic cancer	0.000297	0.00164	CcSEcCtD
Methoxsalen—Nausea—Gemcitabine—pancreatic cancer	0.000293	0.00162	CcSEcCtD
Methoxsalen—Erythema—Epirubicin—pancreatic cancer	0.00029	0.0016	CcSEcCtD
Methoxsalen—Feeling abnormal—Docetaxel—pancreatic cancer	0.000289	0.00159	CcSEcCtD
Methoxsalen—Nausea—Fluorouracil—pancreatic cancer	0.000288	0.00159	CcSEcCtD
Methoxsalen—Tension—Epirubicin—pancreatic cancer	0.000284	0.00157	CcSEcCtD
Methoxsalen—Dysgeusia—Epirubicin—pancreatic cancer	0.000284	0.00156	CcSEcCtD
Methoxsalen—Nervousness—Epirubicin—pancreatic cancer	0.000281	0.00155	CcSEcCtD
Methoxsalen—Muscle spasms—Epirubicin—pancreatic cancer	0.000278	0.00153	CcSEcCtD
Methoxsalen—Body temperature increased—Docetaxel—pancreatic cancer	0.000277	0.00153	CcSEcCtD
Methoxsalen—Arrhythmia—Doxorubicin—pancreatic cancer	0.000275	0.00152	CcSEcCtD
Methoxsalen—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000269	0.00148	CcSEcCtD
Methoxsalen—Erythema—Doxorubicin—pancreatic cancer	0.000268	0.00148	CcSEcCtD
Methoxsalen—Tension—Doxorubicin—pancreatic cancer	0.000263	0.00145	CcSEcCtD
Methoxsalen—Dysgeusia—Doxorubicin—pancreatic cancer	0.000262	0.00145	CcSEcCtD
Methoxsalen—Malaise—Epirubicin—pancreatic cancer	0.000261	0.00144	CcSEcCtD
Methoxsalen—Nervousness—Doxorubicin—pancreatic cancer	0.00026	0.00143	CcSEcCtD
Methoxsalen—Vertigo—Epirubicin—pancreatic cancer	0.00026	0.00143	CcSEcCtD
Methoxsalen—Hypersensitivity—Docetaxel—pancreatic cancer	0.000258	0.00142	CcSEcCtD
Methoxsalen—Muscle spasms—Doxorubicin—pancreatic cancer	0.000258	0.00142	CcSEcCtD
Methoxsalen—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000249	0.00137	CcSEcCtD
Methoxsalen—Pruritus—Docetaxel—pancreatic cancer	0.000248	0.00137	CcSEcCtD
Methoxsalen—Discomfort—Epirubicin—pancreatic cancer	0.000244	0.00134	CcSEcCtD
Methoxsalen—Malaise—Doxorubicin—pancreatic cancer	0.000242	0.00133	CcSEcCtD
Methoxsalen—Vertigo—Doxorubicin—pancreatic cancer	0.000241	0.00133	CcSEcCtD
Methoxsalen—Oedema—Epirubicin—pancreatic cancer	0.000236	0.0013	CcSEcCtD
Methoxsalen—Infection—Epirubicin—pancreatic cancer	0.000235	0.00129	CcSEcCtD
Methoxsalen—Dizziness—Docetaxel—pancreatic cancer	0.000232	0.00128	CcSEcCtD
Methoxsalen—Skin disorder—Epirubicin—pancreatic cancer	0.00023	0.00126	CcSEcCtD
Methoxsalen—Discomfort—Doxorubicin—pancreatic cancer	0.000225	0.00124	CcSEcCtD
Methoxsalen—Rash—Docetaxel—pancreatic cancer	0.000221	0.00122	CcSEcCtD
Methoxsalen—Hypotension—Epirubicin—pancreatic cancer	0.000221	0.00122	CcSEcCtD
Methoxsalen—Dermatitis—Docetaxel—pancreatic cancer	0.000221	0.00122	CcSEcCtD
Methoxsalen—Headache—Docetaxel—pancreatic cancer	0.00022	0.00121	CcSEcCtD
Methoxsalen—Oedema—Doxorubicin—pancreatic cancer	0.000219	0.0012	CcSEcCtD
Methoxsalen—Infection—Doxorubicin—pancreatic cancer	0.000217	0.0012	CcSEcCtD
Methoxsalen—Insomnia—Epirubicin—pancreatic cancer	0.000214	0.00118	CcSEcCtD
Methoxsalen—Skin disorder—Doxorubicin—pancreatic cancer	0.000212	0.00117	CcSEcCtD
Methoxsalen—Nausea—Docetaxel—pancreatic cancer	0.000208	0.00115	CcSEcCtD
Methoxsalen—Dyspepsia—Epirubicin—pancreatic cancer	0.000208	0.00115	CcSEcCtD
Methoxsalen—Hypotension—Doxorubicin—pancreatic cancer	0.000204	0.00113	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000204	0.00112	CcSEcCtD
Methoxsalen—Insomnia—Doxorubicin—pancreatic cancer	0.000198	0.00109	CcSEcCtD
Methoxsalen—Feeling abnormal—Epirubicin—pancreatic cancer	0.000195	0.00107	CcSEcCtD
Methoxsalen—Dyspepsia—Doxorubicin—pancreatic cancer	0.000193	0.00106	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000189	0.00104	CcSEcCtD
Methoxsalen—Urticaria—Epirubicin—pancreatic cancer	0.000188	0.00103	CcSEcCtD
Methoxsalen—Body temperature increased—Epirubicin—pancreatic cancer	0.000187	0.00103	CcSEcCtD
Methoxsalen—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00018	0.000993	CcSEcCtD
Methoxsalen—Hypersensitivity—Epirubicin—pancreatic cancer	0.000174	0.000959	CcSEcCtD
Methoxsalen—Urticaria—Doxorubicin—pancreatic cancer	0.000174	0.000957	CcSEcCtD
Methoxsalen—Body temperature increased—Doxorubicin—pancreatic cancer	0.000173	0.000952	CcSEcCtD
Methoxsalen—Pruritus—Epirubicin—pancreatic cancer	0.000167	0.000921	CcSEcCtD
Methoxsalen—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000161	0.000888	CcSEcCtD
Methoxsalen—Dizziness—Epirubicin—pancreatic cancer	0.000156	0.000861	CcSEcCtD
Methoxsalen—Pruritus—Doxorubicin—pancreatic cancer	0.000155	0.000852	CcSEcCtD
Methoxsalen—Rash—Epirubicin—pancreatic cancer	0.000149	0.000821	CcSEcCtD
Methoxsalen—Dermatitis—Epirubicin—pancreatic cancer	0.000149	0.00082	CcSEcCtD
Methoxsalen—Headache—Epirubicin—pancreatic cancer	0.000148	0.000816	CcSEcCtD
Methoxsalen—Dizziness—Doxorubicin—pancreatic cancer	0.000145	0.000797	CcSEcCtD
Methoxsalen—Nausea—Epirubicin—pancreatic cancer	0.00014	0.000773	CcSEcCtD
Methoxsalen—Rash—Doxorubicin—pancreatic cancer	0.000138	0.00076	CcSEcCtD
Methoxsalen—Dermatitis—Doxorubicin—pancreatic cancer	0.000138	0.000759	CcSEcCtD
Methoxsalen—Headache—Doxorubicin—pancreatic cancer	0.000137	0.000755	CcSEcCtD
Methoxsalen—Nausea—Doxorubicin—pancreatic cancer	0.00013	0.000716	CcSEcCtD
